GlassScriptPhysician profile
Richard A Clark
NPI 1033421243
$14,914.11
in general payments reported to CMS, 2019-2025
60 companies · $2,671 in 2025
The $2,671 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,360 · 2022: $3,278 · 2023: $3,052 · 2024: $2,553 · 2025: $2,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,252 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,251.50 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,867.04 | 2021-2025 | |
| Novo Nordisk INC | $1,628.69 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $1,477.62 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $962.43 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $910.63 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $870.12 | 2022-2025 | Farxiga, Airsupra |
| Janssen Pharmaceuticals, INC | $693.90 | 2021-2023 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $532.39 | 2021-2025 | Jardiance |
| Exact Sciences Corporation | $486.82 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $406.02 | 2021-2025 | Repatha, Otezla, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $340.53 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $320.33 | 2021-2025 | Xifaxan |
| Astellas Pharma US INC | $268.83 | 2021-2025 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $255.56 | 2021-2024 | Belsomra, Steglatro, Gardasil 9 |
| Sanofi-Aventis U.S. LLC | $210.50 | 2021-2025 |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $193.85 | 2021-2023 | Seglentis |
| Phathom Pharmaceuticals, INC. | $191.76 | 2025 | Voquezna |
| Electromed, INC. | $182.79 | 2022 | |
| Novartis Pharmaceuticals Corporation | $181.94 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $164.87 | 2023-2025 | Gemtesa |
| Abbott Laboratories | $152.56 | 2021-2025 | Freestyle Libre 3 |
| E.R. Squibb & Sons, L.L.C. | $148.79 | 2022-2025 | Eliquis, Camzyos |
| Amarin Pharma, INC. | $131.93 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $128.90 | 2022 | |
| Paratek Pharmaceuticals, INC. | $127.18 | 2022-2025 | Nuzyra |
| Biohaven Pharmaceuticals, INC. | $127.14 | 2021 | |
| Ibsa Pharma INC. | $126.99 | 2021-2025 | Tirosint, Licart, Flector |
| Viiv Healthcare Company | $125.74 | 2022-2025 | Apretude |
| Currax Pharmaceuticals LLC | $120.01 | 2021-2023 | Nexletol |
| Dexcom, INC. | $103.41 | 2021-2024 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $102.02 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Esperion Therapeutics, INC. | $99.34 | 2021 | |
| Vanda Pharmaceuticals INC. | $99.27 | 2021 | |
| Axsome Therapeutics, INC. | $80.78 | 2025 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $80.62 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $77.99 | 2021 | |
| Mannkind Corporation | $74.26 | 2023 | Afrezza |
| Optinose US, INC. | $73.34 | 2025 | |
| Sunovion Pharmaceuticals INC. | $61.58 | 2022 | |
| Idorsia Pharmaceuticals US INC | $59.53 | 2022-2023 | Quviviq |
| Sanofi Pasteur INC. | $55.49 | 2021-2023 | |
| Lundbeck LLC | $53.56 | 2023-2024 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $49.67 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $47.60 | 2025 | Neffy |
| Eisai INC. | $47.20 | 2021 | |
| Jazz Pharmaceuticals INC. | $46.03 | 2021-2022 | |
| Boston Scientific Corporation | $44.02 | 2025 | General - Pain Management |
| Tolmar, INC. | $42.53 | 2025 | Jatenzo |
| Ucb, INC. | $35.35 | 2023 | Nayzilam |
| Halozyme INC | $34.40 | 2023 | |
| Renalytix Ai, INC. | $30.25 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Gilead Sciences, INC. | $29.43 | 2023-2025 | |
| Amneal Pharmaceuticals LLC | $27.21 | 2021 | |
| Seqirus USA INC | $22.06 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Avanir Pharmaceuticals, INC. | $21.09 | 2022 | |
| Aimmune Therapeutics, INC. | $17.96 | 2025 | Zenpep |
| Clarus Therapeutics INC. | $16.03 | 2021 | |
| Kaleo, INC. | $15.73 | 2021 | |
| La Jolla Pharmaceutical Company | $15.58 | 2021 | |
| Almatica Pharma LLC | $14.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.